Modified GRF (1-29) Peptide 2mg Vial – GHRH Research Peptide

What Is Modified GRF (1-29)?

Modified GRF (1-29), also known as a refined GHRH analog, is a synthetic peptide widely used in growth hormone research. Designed for improved stability, it mimics natural growth hormone-releasing hormone while offering more consistent performance in laboratory settings.

CAS-nummer	863288-34-0
Andra namn	Modified GRF (1-29), Tetrasubstituted GRF (1-29),
IUPAC-namn	Ej tillämpligt
Molekylformel	C₁₅₂H₂₅₂N₄₄O₄₂
Molekylvikt	3367.95
Renhet	≥99% Pure (LC-MS)
Tillgång på vätska	Ej tillämpligt
Pulvertillgänglighet	2 milligrams (lyophilized/freeze-dried)
Förvaringsförhållande	Förvara svalt, förvaras i kylskåp. Får EJ frysas.
Villkor	Alla produkter är endast avsedda för användning inom laboratorieutveckling och forskning. Produkterna är inte avsedda för mänsklig konsumtion.

---

How It Works

Growth Hormone Signaling Support

This peptide binds to GHRH receptors in the pituitary gland, helping researchers study pulsatile growth hormone release—a key factor in understanding endocrine balance and metabolic processes.

---

Why Choose a 2mg Vial?

Precision & Flexibility

The 2mg lyophilized format allows:

• Accurate measurement

• Controlled dosing in experiments

• Reliable storage and handling

Researchers often value its predictable response and stability, making it a dependable tool in peptide studies.

---

Storage Guidelines

• Store in a cool, dry place

• Refrigerate at 2–8°C after reconstitution

• Avoid repeated freeze–thaw cycles

---

Vanliga frågor

What is Modified GRF (1-29) used for?

It is used in research involving growth hormone release and endocrine signaling.

How is it different from CJC-1295 with DAC?

It has a shorter action, allowing more natural hormone release patterns.

Is it for human use?

No, it is strictly for laboratory research purposes only.